These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29975121)

  • 1. Should we really STOP treating patients with IgA nephropathy with steroids?
    Locatelli F; Del Vecchio L; Ponticelli C
    Physiol Int; 2018 Jun; 105(2):101-109. PubMed ID: 29975121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Considerations on the treatment of IgA nephropathy on the basis of the results of the latest studies (STOP-IgAN, TESTING, NEFIGAN)].
    Nagy J; Sági B; Máté J; Vas T; Kovács T
    Orv Hetil; 2017 Dec; 158(49):1946-1952. PubMed ID: 29199436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid therapy in children with IgA nephropathy.
    Cambier A; Boyer O; Deschenes G; Gleeson J; Couderc A; Hogan J; Robert T
    Pediatr Nephrol; 2020 Mar; 35(3):359-366. PubMed ID: 30778826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid for IgA Nephropathy: Are They Really Therapeutic?
    Lin Y; Jia J; Guo Y; He D; Zhang Y; Wang F; Yan T; Liu Y; Lin S
    Am J Nephrol; 2018; 47(6):385-394. PubMed ID: 29874651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
    Wong MG; Lv J; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Zhao M; Barbour S; Reich HN; Cattran D; Glassock R; Levin A; Jardine MJ; Wheeler DC; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Zhang H; Perkovic V;
    Am J Nephrol; 2021; 52(10-11):827-836. PubMed ID: 34731857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C
    G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of IgA nephropathy: Recent advances and prospects.
    Coppo R
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S13-S21. PubMed ID: 29606258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of glucocorticoids for patients with IgA nephropathy: a meta-analysis.
    Qian G; Zhang X; Xu W; Zou H; Li Y
    Int Urol Nephrol; 2019 May; 51(5):859-868. PubMed ID: 30843135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of proteinuria reduction in the progression of IgA nephropathy.
    Locatelli F; Pozzi C; Del Vecchio L; Bolasco PG; Fogazzi GB; Andrulli S; Melis P; Altieri P; Ponticelli C
    Ren Fail; 2001; 23(3-4):495-505. PubMed ID: 11499564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and targeted steroids for the treatment of IgA nephropathy.
    Locatelli F; Del Vecchio L; Ponticelli C
    Clin Kidney J; 2023 Dec; 16(Suppl 2):ii40-ii46. PubMed ID: 38053978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F; Vecchio LD; Pozzi C
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
    Eitner F; Ackermann D; Hilgers RD; Floege J
    J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mycophenolate mofetil in the treatment for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Peng XJ; Zheng WM; Fu R; Huang YH; Deng MH; Tao SS; Wang TJ; Zhu C
    Clin Exp Nephrol; 2021 Jul; 25(7):788-801. PubMed ID: 33710500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
    Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
    Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal corticosteroid therapy of IgA nephropathy.
    Floege J
    Kidney Int; 2017 Aug; 92(2):278-280. PubMed ID: 28709593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
    Inker LA; Mondal H; Greene T; Masaschi T; Locatelli F; Schena FP; Katafuchi R; Appel GB; Maes BD; Li PK; Praga M; Del Vecchio L; Andrulli S; Manno C; Gutierrez E; Mercer A; Carroll KJ; Schmid CH; Levey AS
    Am J Kidney Dis; 2016 Sep; 68(3):392-401. PubMed ID: 27032886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness and safety for the treatments despite optimized renin-angiotensin system blockade among IgA nephropathy patients at high-risk of disease progression: A network meta-analysis of randomized controlled trials.
    Tan Q; Xue H; Ni X; Fan L; Du W
    Eur J Intern Med; 2023 Aug; 114():66-73. PubMed ID: 37179138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.